Clinical Trial Update: Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of colchicine in adults and adolescents with obesity to suppress inflammation and improve insulin resistance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Obesity, Insulin Resistance | Phase 2 | Status: COMPLETED